Kraitchman DL - Search Results

1

Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis.

Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Kostura L, et al. Among authors: kraitchman dl. NMR Biomed. 2004 Nov;17(7):513-7. doi: 10.1002/nbm.925. NMR Biomed. 2004. PMID: 15526348

2

Real-Time High-Resolution MRI Endoscopy at up to 10 Frames per Second.

Liu X, Karmarkar P, Voit D, Frahm J, Weiss CR, Kraitchman DL, Bottomley PA. Liu X, et al. Among authors: kraitchman dl. BME Front. 2021 Feb 17;2021:6185616. doi: 10.34133/2021/6185616. eCollection 2021. BME Front. 2021. PMID: 37849906 Free PMC article.

3

In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW. Kraitchman DL, et al. Circulation. 2003 May 13;107(18):2290-3. doi: 10.1161/01.CIR.0000070931.62772.4E. Epub 2003 May 5. Circulation. 2003. PMID: 12732608 Free article.

4

111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction.

Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL. Chin BB, et al. Among authors: kraitchman dl. Nucl Med Commun. 2003 Nov;24(11):1149-54. doi: 10.1097/00006231-200311000-00005. Nucl Med Commun. 2003. PMID: 14569169

5

MR-trackable intramyocardial injection catheter.

Karmarkar PV, Kraitchman DL, Izbudak I, Hofmann LV, Amado LC, Fritzges D, Young R, Pittenger M, Bulte JW, Atalar E. Karmarkar PV, et al. Among authors: kraitchman dl. Magn Reson Med. 2004 Jun;51(6):1163-72. doi: 10.1002/mrm.20086. Magn Reson Med. 2004. PMID: 15170836 Free article.

6

Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.

Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Bulte JW, et al. Among authors: kraitchman dl. Blood. 2004 Nov 15;104(10):3410-2; author reply 3412-3. doi: 10.1182/blood-2004-06-2117. Blood. 2004. PMID: 15525839 Free article. No abstract available.

7

Iron oxide MR contrast agents for molecular and cellular imaging.

Bulte JW, Kraitchman DL. Bulte JW, et al. Among authors: kraitchman dl. NMR Biomed. 2004 Nov;17(7):484-99. doi: 10.1002/nbm.924. NMR Biomed. 2004. PMID: 15526347 Review.

8

Monitoring cell therapy using iron oxide MR contrast agents.

Bulte JW, Kraitchman DL. Bulte JW, et al. Among authors: kraitchman dl. Curr Pharm Biotechnol. 2004 Dec;5(6):567-84. doi: 10.2174/1389201043376526. Curr Pharm Biotechnol. 2004. PMID: 15579045 Review.

9

Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model.

Bulte JW, Kostura L, Mackay A, Karmarkar PV, Izbudak I, Atalar E, Fritzges D, Rodriguez ER, Young RG, Marcelino M, Pittenger MF, Kraitchman DL. Bulte JW, et al. Among authors: kraitchman dl. Acad Radiol. 2005 May;12 Suppl 1:S2-6. doi: 10.1016/j.acra.2005.02.014. Acad Radiol. 2005. PMID: 16106536 No abstract available.

10

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction.

Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BM, Wahl RL, Bulte JW. Kraitchman DL, et al. Circulation. 2005 Sep 6;112(10):1451-61. doi: 10.1161/CIRCULATIONAHA.105.537480. Epub 2005 Aug 29. Circulation. 2005. PMID: 16129797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page